Scheduling shake-up

Australian regulators have flagged a potential liberalising of the medicine scheduling regime, with a range of widely used drugs recommended for down-scheduling.

The newly released scheduling proposals, from the November 2015 meeting of the Advisory Committee on Medicines Scheduling (ACMS), reveal proposed changes for PPIs, paracetamol–ibuprofen combination product and the NSAID naproxen.

The ACMS delegate has recommended the